RxDoctor Payments Data

Mark Purnell, MD

Orthopedic Surgery · Basalt, CONPI 1457315566

Payments from drug & device makers

What this record shows

This record is dominated by other: $9,071 of the $10,438 with a category attached, or 86.9%. Olympus America Inc. accounts for 86.9% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2023 at $9,071 and has fallen 99.8% since, to $16 in 2025.

$10,438in general payments, 2019–2025

Across 9 payments — averaging $1159.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Olympus America Inc.$9K
  • Gemini Mountain Medical, LLC$1K
  • Pacira Pharmaceuticals Incorporated$106
  • Amgen$29
  • Johnson & Johnson$17
  • Vertex$16

What the payments were for

  • Food & beverage$1672%
  • Education$1,20011%
  • Other$9,07187%

General payments by program year

20
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

Too few orthopedic surgery providers in Coloradoto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$107,128
Medicare patients
168
Services billed
3,543

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other orthopedic surgery in Basalt

Where these figures come from

Is this you, or does something look wrong? →